Yemaachi Furthers African Cancer Research Agenda With New Breast Cancer Mutation, Research Networks
![](https://www.yemaachi.com/wp-content/uploads/2023/11/iStock-898620334-1024x640.jpg)
Yemaachi Biotech is preparing to expand a whole-exome sequencing pilot study, while pushing forward several other pan-African cancer research initiatives.
African scientists call for research equity as a cancer crisis looms
![](https://www.yemaachi.com/wp-content/uploads/2023/11/d41586-023-02610-9_25999982.webp)
At Yemaachi, Bediako is developing cancer diagnostics and treatments tailored to Africans, and he describes the limited official data on patients with cancer across Africa as a major challenge.
Liquid Biopsy – The necessary first step towards democratising precision oncology?African biotech holds the key to transforming not just the health of African people, but our economies as well
![](https://www.yemaachi.com/wp-content/uploads/2023/02/1675083715756.jpeg)
While IHC and imaging are useful for diagnosing and staging cancers, they are limited in their ability to inform clinical decision-making regarding the use of increasingly available targeted therapies that are revolutionising cancer care in developed countries. For this, more advanced molecular tests are required, and next generation sequencing-based liquid biopsy tests are at the cutting edge.
African biotech holds the key to transforming not just the health of African people, but our economies as well
![](https://www.yemaachi.com/wp-content/uploads/2022/11/Screenshot-2023-02-14-at-10.55.28-AM.png)
Why has over a decade of political rhetoric and unprecedented donor support for scientific capacity building not translated into more tangible scientific output?
A closer look reveals a glaring gap in the current structure of the scientific ecosystem in Africa – the almost complete absence of the private sector.
This YC Summer batch features the largest group of African startups yet
![](https://www.yemaachi.com/wp-content/uploads/2022/03/yc-africa2.jpg-1024x575.webp)
Tech Crunch profiles Yemaachi Biotech and the other 14 African Startups that were selected to be a part of Y Combinator’s summer batch of 2021.
“The Scientist” Feature: Quest for Research Freedom Fuels African Biotech Boom
![](https://www.yemaachi.com/wp-content/uploads/2022/03/07-2021-cover-s-e1647816279687.jpg)
Tired of dancing to the tunes of international funders, and doubtful that long-promised national grants will come, a handful of African biomedical scientists have turned to private investors to bankroll their dreams of autonomy in the lab